226 related articles for article (PubMed ID: 34250592)
1. A comparison of methods for measuring spatial access to health care.
Drake C; Nagy D; Nguyen T; Kraemer KL; Mair C; Wallace D; Donohue J
Health Serv Res; 2021 Oct; 56(5):777-787. PubMed ID: 34250592
[TBL] [Abstract][Full Text] [Related]
2. Geographic access to buprenorphine prescribers for patients who use public transit.
Drake C; Donohue JM; Nagy D; Mair C; Kraemer KL; Wallace DJ
J Subst Abuse Treat; 2020 Oct; 117():108093. PubMed ID: 32811632
[TBL] [Abstract][Full Text] [Related]
3. Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky.
Shrestha S; Lindstrom MR; Harris D; Rock P; Srinivasan S; Pustz JC; Bayly R; Stopka TJ
J Subst Use Addict Treat; 2023 Jul; 150():209077. PubMed ID: 37211155
[TBL] [Abstract][Full Text] [Related]
4. County-level access to opioid use disorder medications in medicare Part D (2010-2015).
Abraham AJ; Adams GB; Bradford AC; Bradford WD
Health Serv Res; 2019 Apr; 54(2):390-398. PubMed ID: 30665272
[TBL] [Abstract][Full Text] [Related]
5. Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior.
Mitchell P; Samsel S; Curtin KM; Price A; Turner D; Tramp R; Hudnall M; Parton J; Lewis D
Soc Sci Med; 2022 Jun; 302():114992. PubMed ID: 35512612
[TBL] [Abstract][Full Text] [Related]
6. Potential accessibility scores for hospital care in a province of Japan: GIS-based ecological study of the two-step floating catchment area method and the number of neighborhood hospitals.
Nakamura T; Nakamura A; Mukuda K; Harada M; Kotani K
BMC Health Serv Res; 2017 Jun; 17(1):438. PubMed ID: 28651532
[TBL] [Abstract][Full Text] [Related]
7. Accessibility to primary health care in Belgium: an evaluation of policies awarding financial assistance in shortage areas.
Dewulf B; Neutens T; De Weerdt Y; Van de Weghe N
BMC Fam Pract; 2013 Aug; 14():122. PubMed ID: 23964751
[TBL] [Abstract][Full Text] [Related]
8. U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018.
Ghertner R
Drug Alcohol Depend; 2019 Nov; 204():107527. PubMed ID: 31525570
[TBL] [Abstract][Full Text] [Related]
9. Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use Disorder.
Anyanwu P; Varisco TJ; Wanat MA; Bapat S; Claborn K; Thornton JD
J Pain Palliat Care Pharmacother; 2022 Jun; 36(2):103-111. PubMed ID: 35648731
[TBL] [Abstract][Full Text] [Related]
10. Spatial Access to Primary Care Providers in Appalachia: Evaluating Current Methodology.
Donohoe J; Marshall V; Tan X; Camacho FT; Anderson RT; Balkrishnan R
J Prim Care Community Health; 2016 Jul; 7(3):149-58. PubMed ID: 26906524
[TBL] [Abstract][Full Text] [Related]
11. Measuring spatial equity and access to maternal health services using enhanced two step floating catchment area method (E2SFCA) - a case study of the Indian Sundarbans.
Vadrevu L; Kanjilal B
Int J Equity Health; 2016 Jun; 15():87. PubMed ID: 27268153
[TBL] [Abstract][Full Text] [Related]
12. Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine Treatment Across the Rural-Urban and Area Deprivation Continua: A US Nationwide Small Area Analysis.
Amiri S; McDonell MG; Denney JT; Buchwald D; Amram O
Value Health; 2021 Feb; 24(2):188-195. PubMed ID: 33518025
[TBL] [Abstract][Full Text] [Related]
13. Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire.
Cao Y; Stewart K; Wish E; Artigiani E; Sorg MH
J Subst Abuse Treat; 2019 Jun; 101():55-66. PubMed ID: 31174714
[TBL] [Abstract][Full Text] [Related]
14. Challenging terrains: socio-spatial analysis of Primary Health Care Access Disparities in West Virginia.
Hong I; Wilson B; Gross T; Conley J; Powers T
Appl Spat Anal Policy; 2023; 16(1):141-161. PubMed ID: 35967757
[TBL] [Abstract][Full Text] [Related]
15. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
[TBL] [Abstract][Full Text] [Related]
16. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
Wen H; Hockenberry JM; Pollack HA
JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the spatial accessibility to health professionals at French census block level.
Gao F; Kihal W; Le Meur N; Souris M; Deguen S
Int J Equity Health; 2016 Aug; 15(1):125. PubMed ID: 27485740
[TBL] [Abstract][Full Text] [Related]
18. Disparities in Spatial Access to Emergency Surgical Services in the US.
McCrum ML; Wan N; Han J; Lizotte SL; Horns JJ
JAMA Health Forum; 2022 Oct; 3(10):e223633. PubMed ID: 36239953
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Disparities in Geographic Availability of Buprenorphine.
Drake C; Nagy D; Meiselbach MK; Zhu JM; Saloner B; Stein BD; Polsky D
J Addict Med; 2024 May-Jun 01; 18(3):335-338. PubMed ID: 38833558
[TBL] [Abstract][Full Text] [Related]
20. Rural and frontier access to mental health prescribers and nonprescribers: A geospatial analysis in Oregon Medicaid.
Charlesworth CJ; Nagy D; Drake C; Manibusan B; Zhu JM
J Rural Health; 2024 Jan; 40(1):16-25. PubMed ID: 37088967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
